Active Ingredient(s): Darunavir + Cobicistat + Emtricitabine + Tenofovir Alafenamide
FDA Approved: * July 17, 2018
Pharm Company: * JANSSEN PRODS
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Symtuza Overview

Some of these combinations are complete single-tablet regimens; the others must be combined with additional pills to make a treatment regimen. Brand name(s) Ingredients (INN) FDA approval date Company Single-tablet regimen? NRTIs / NtRTIs NNRTI INSTI PI PK enhancer Combivir lamivudinezidovudine September 26, 1997 ViiV Healthcare No Kaletra (developed countries)Aluvia (developing countries) lopinavir ritonavir September 15, 2000 Abbott Laboratories No ...

Read more Symtuza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Symtuza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Darunavir + Cobicistat + Emtricitabine + Tenofovir Alafenamide
  • Tablet: 150mg + 800mg + 200mg + 10mg, 800mg + 150mg + 200mg + 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Symtuza: (1 result)

Sorted by National Drug Code
  • 59676-800 Symtuza Oral Tablet, Film Coated by Janssen Products Lp

Drugs with one or more similar ingredients: (26 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 October 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA